ROCKWELL MEDICAL INC(NASDAQ:RMTI) stock Fundamental Analysis

Fundamental Rating

Taking everything into account, RMTI scores 4 out of 10 in our fundamental rating. RMTI was compared to 189 industry peers in the Health Care Equipment & Supplies industry. While RMTI seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, RMTI is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year RMTI has reported negative net income.

In the past year RMTI had a positive cash flow from operations.

RMTI had negative earnings in each of the past 5 years.

In the past 5 years RMTI reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -0.81%, RMTI is in the better half of the industry, outperforming 71.96% of the companies in the same industry.

The Return On Equity of RMTI (-1.47%) is better than 73.55% of its industry peers.

RMTI has a better Return On Invested Capital (1.06%) than 68.25% of its industry peers.

		Industry Rank	Sector Rank
ROA	-0.81%
ROE	-1.47%
ROIC	1.06%

ROA(3y)-19.01%

ROA(5y)-32.81%

ROE(3y)-57.83%

ROE(5y)-310.02%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 0.60%, RMTI is in the better half of the industry, outperforming 66.14% of the companies in the same industry.

The Gross Margin of RMTI (17.23%) is worse than 79.89% of its industry peers.

RMTI's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	0.6%
PM (TTM)	N/A
GM	17.23%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y30.04%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), RMTI is destroying value.

Compared to 1 year ago, RMTI has more shares outstanding

The number of shares outstanding for RMTI has been increased compared to 5 years ago.

The debt/assets ratio for RMTI has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -6.42, we must say that RMTI is in the distress zone and has some risk of bankruptcy.

RMTI's Altman-Z score of -6.42 is on the low side compared to the rest of the industry. RMTI is outperformed by 74.07% of its industry peers.

The Debt to FCF ratio of RMTI is 3.22, which is a good value as it means it would take RMTI, 3.22 years of fcf income to pay off all of its debts.

RMTI has a Debt to FCF ratio of 3.22. This is amongst the best in the industry. RMTI outperforms 86.77% of its industry peers.

A Debt/Equity ratio of 0.30 indicates that RMTI is not too dependend on debt financing.

With a Debt to Equity ratio value of 0.30, RMTI perfoms like the industry average, outperforming 50.26% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.3
Debt/FCF	3.22
Altman-Z	-6.42

ROIC/WACC0.12

WACC8.56%

2.3 Liquidity

A Current Ratio of 2.63 indicates that RMTI has no problem at all paying its short term obligations.

The Current ratio of RMTI (2.63) is comparable to the rest of the industry.

A Quick Ratio of 2.22 indicates that RMTI has no problem at all paying its short term obligations.

Looking at the Quick ratio, with a value of 2.22, RMTI is in line with its industry, outperforming 52.38% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.63
Quick Ratio	2.22

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

RMTI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 99.72%, which is quite impressive.

The Revenue has grown by 21.38% in the past year. This is a very strong growth!

Measured over the past years, RMTI shows a quite strong growth in Revenue. The Revenue has been growing by 10.61% on average per year.

EPS 1Y (TTM)99.72%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%33.33%

Revenue 1Y (TTM)21.38%

Revenue growth 3Y17.9%

Revenue growth 5Y10.61%

Sales Q2Q%-16.59%

3.2 Future

Based on estimates for the next years, RMTI will show a very negative growth in Earnings Per Share. The EPS will decrease by -156.07% on average per year.

RMTI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.83% yearly.

EPS Next Y-701.43%

EPS Next 2Y-156.07%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-32.01%

Revenue Next 2Y-13.38%

Revenue Next 3Y13.83%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Forward Price/Earnings Ratio is negative for RMTI. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RMTI is valued cheaply inside the industry as 96.83% of the companies are valued more expensively.

95.77% of the companies in the same industry are more expensive than RMTI, based on the Price/Free Cash Flow ratio.

		Industry Rank	Sector Rank
P/FCF	10.67
EV/EBITDA	5.91

4.3 Compensation for Growth

A cheap valuation may be justified as RMTI's earnings are expected to decrease with -156.07% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-156.07%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

RMTI does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ROCKWELL MEDICAL INC

NASDAQ:RMTI (5/22/2025, 4:30:02 PM)

After market: 0.9801 -0.02 (-1.67%)

0.9967

+0 (+0.1%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)05-12 2025-05-12/bmo

Earnings (Next)08-06 2025-08-06

Inst Owners25.7%

Inst Owner Change-14.28%

Ins Owners2.06%

Ins Owner Change0.48%

Market Cap34.06M

Analysts82.5

Price Target4.08 (309.35%)

Short Float %0.65%

Short Ratio0.73

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)96.08%

Min EPS beat(2)-198.04%

Max EPS beat(2)390.2%

EPS beat(4)2

Avg EPS beat(4)67.58%

Min EPS beat(4)-198.04%

Max EPS beat(4)390.2%

EPS beat(8)5

Avg EPS beat(8)41.06%

EPS beat(12)9

Avg EPS beat(12)37.2%

EPS beat(16)11

Avg EPS beat(16)33.46%

Revenue beat(2)2

Avg Revenue beat(2)3.5%

Min Revenue beat(2)2.23%

Max Revenue beat(2)4.77%

Revenue beat(4)4

Avg Revenue beat(4)4.98%

Min Revenue beat(4)2.23%

Max Revenue beat(4)10.49%

Revenue beat(8)6

Avg Revenue beat(8)2.07%

Revenue beat(12)8

Avg Revenue beat(12)1.69%

Revenue beat(16)8

Avg Revenue beat(16)-2.47%

PT rev (1m)0%

PT rev (3m)-38.46%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-42.86%

EPS NY rev (1m)0%

EPS NY rev (3m)-200%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-8.7%

Revenue NY rev (1m)1.33%

Revenue NY rev (3m)-17.87%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.34
P/FCF	10.67
P/OCF	8.11
P/B	1.05
P/tB	1.59
EV/EBITDA	5.91

EPS(TTM)0

EYN/A

EPS(NY)-0.14

Fwd EYN/A

FCF(TTM)0.09

FCFY9.37%

OCF(TTM)0.12

OCFY12.34%

SpS2.97

BVpS0.95

TBVpS0.63

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-0.81%
ROE	-1.47%
ROCE	1.35%
ROIC	1.06%
ROICexc	2.02%
ROICexgc	3.8%
OM	0.6%
PM (TTM)	N/A
GM	17.23%
FCFM	3.14%

ROA(3y)-19.01%

ROA(5y)-32.81%

ROE(3y)-57.83%

ROE(5y)-310.02%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y30.04%

F-Score7

Asset Turnover1.71

Health

		Industry Rank	Sector Rank
Debt/Equity	0.3
Debt/FCF	3.22
Debt/EBITDA	3.47
Cap/Depr	46.38%
Cap/Sales	1%
Interest Coverage	0.72
Cash Conversion	150.72%
Profit Quality	N/A
Current Ratio	2.63
Quick Ratio	2.22
Altman-Z	-6.42

F-Score7

WACC8.56%

ROIC/WACC0.12

Cap/Depr(3y)323.45%

Cap/Depr(5y)234.89%

Cap/Sales(3y)5.5%

Cap/Sales(5y)3.81%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)99.72%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%33.33%

EPS Next Y-701.43%

EPS Next 2Y-156.07%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)21.38%

Revenue growth 3Y17.9%

Revenue growth 5Y10.61%

Sales Q2Q%-16.59%

Revenue Next Year-32.01%

Revenue Next 2Y-13.38%

Revenue Next 3Y13.83%

Revenue Next 5YN/A

EBIT growth 1Y109.11%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-289.03%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y114.47%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y144.65%

OCF growth 3YN/A

OCF growth 5YN/A

ROCKWELL MEDICAL INC (RMTI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens